Yuchun Lee is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 1,875 shares of VRTX, which is worth approximately $942,093. The most recent transaction as insider was on Jan 27, 2023, when has been sold 1,429 shares (Common Stock) at a price of $322.28 per share, resulting in proceeds of $460,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.88K
0% 3M change
0% 12M change
Total Value Held $942,093

Yuchun Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 27 2023
SELL
Open market or private sale
$460,538 $322.28 p/Share
1,429 Reduced 43.25%
1,875 Common Stock
Jan 27 2023
BUY
Exercise of conversion of derivative security
$103,088 $72.14 p/Share
1,429 Added 30.19%
3,304 Common Stock
Jan 26 2023
SELL
Open market or private sale
$1,273,760 $318.44 p/Share
4,000 Reduced 68.09%
1,875 Common Stock
Jan 26 2023
BUY
Exercise of conversion of derivative security
$288,560 $72.14 p/Share
4,000 Added 40.51%
5,875 Common Stock
Jan 25 2023
SELL
Open market or private sale
$1,255,800 $313.95 p/Share
4,000 Reduced 68.09%
1,875 Common Stock
Jan 25 2023
BUY
Exercise of conversion of derivative security
$288,560 $72.14 p/Share
4,000 Added 40.51%
5,875 Common Stock
Jan 24 2023
SELL
Open market or private sale
$1,251,280 $312.82 p/Share
4,000 Reduced 68.09%
1,875 Common Stock
Jan 24 2023
BUY
Exercise of conversion of derivative security
$288,560 $72.14 p/Share
4,000 Added 40.51%
5,875 Common Stock
Jan 23 2023
SELL
Open market or private sale
$664,290 $312.02 p/Share
2,129 Reduced 53.17%
1,875 Common Stock
Jan 23 2023
BUY
Exercise of conversion of derivative security
$153,586 $72.14 p/Share
2,129 Added 34.71%
4,004 Common Stock
Jan 18 2023
SELL
Open market or private sale
$137,979 $312.17 p/Share
442 Reduced 19.08%
1,875 Common Stock
Jan 18 2023
BUY
Exercise of conversion of derivative security
$31,885 $72.14 p/Share
442 Added 16.02%
2,317 Common Stock
Jan 17 2023
SELL
Open market or private sale
$1,248,120 $312.03 p/Share
4,000 Reduced 68.09%
1,875 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
$288,560 $72.14 p/Share
4,000 Added 40.51%
5,875 Common Stock
Apr 18 2022
SELL
Open market or private sale
$569,360 $284.68 p/Share
2,000 Reduced 51.61%
1,875 Common Stock
Apr 18 2022
BUY
Exercise of conversion of derivative security
$163,080 $81.54 p/Share
2,000 Added 34.04%
3,875 Common Stock
Apr 14 2022
SELL
Open market or private sale
$578,900 $289.45 p/Share
2,000 Reduced 51.61%
1,875 Common Stock
Apr 14 2022
BUY
Exercise of conversion of derivative security
$163,080 $81.54 p/Share
2,000 Added 34.04%
3,875 Common Stock
Apr 13 2022
SELL
Open market or private sale
$573,400 $286.7 p/Share
2,000 Reduced 51.61%
1,875 Common Stock
Apr 13 2022
BUY
Exercise of conversion of derivative security
$163,080 $81.54 p/Share
2,000 Added 34.04%
3,875 Common Stock
Apr 12 2022
SELL
Open market or private sale
$562,340 $281.17 p/Share
2,000 Reduced 51.61%
1,875 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
$163,080 $81.54 p/Share
2,000 Added 34.04%
3,875 Common Stock
Apr 11 2022
SELL
Open market or private sale
$561,340 $280.67 p/Share
2,000 Reduced 51.61%
1,875 Common Stock
Apr 11 2022
BUY
Exercise of conversion of derivative security
$163,080 $81.54 p/Share
2,000 Added 34.04%
3,875 Common Stock
Apr 08 2022
SELL
Open market or private sale
$556,820 $278.41 p/Share
2,000 Reduced 51.61%
1,875 Common Stock
YL

Yuchun Lee

Director
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX